Kim, In-Suk <br/><br/>
Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome P450 2C19 genotype.  [electronic resource] 

 -  JACC. Cardiovascular interventions  Apr 2011 
 - 381-91 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1876-7605 
<br/><br/><label>Standard No.: </label>10.1016/j.jcin.2010.12.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Diphosphate<br/>Aged<br/>Angioplasty, Balloon, Coronary--adverse effects<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Aspirin--administration & dosage<br/>Chi-Square Distribution<br/>Cilostazol<br/>Clopidogrel<br/>Cytochrome P-450 CYP2C19<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Humans<br/>Korea<br/>Liver--enzymology<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--blood<br/>Phenotype<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Platelet Function Tests<br/>Predictive Value of Tests<br/>Regression Analysis<br/>Risk Assessment<br/>Risk Factors<br/>Tetrazoles--administration & dosage<br/>Thrombosis--blood<br/>Ticlopidine--administration & dosage<br/>Treatment Outcome